glp-1 drugs wiki A Comprehensive Review of the Role of Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Semaglutide - Wikipedia
Description
Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)
Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)
The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157
New users of GLP-1RAs were matched based on age, demographics, comorbidities and medication use by using 1:1 propensity matching with other glucose-lowering drugs
With the emergence of GLP-1s, there is a divide between patient perception of the medication and how clinical science views it
The liver data may be even more important for employers
